Covid 19 Decision Support and Evidence

 

Point of care / decision support

BMJ Best Practice –

Dynamed –

UptoDate –

 

Guidelines

Department of Health and Social Care -

EC4H -

European Society of Intensive Care Medicine & Society of Critical Care Medicine -

Healthcare Improvement Scotland -

Health Protection Scotland -

NHS Employers –

NHS England -

NICE –

Public Health England –

Scottish Care -

Scottish Government -

Scottish Palliative Care Guidelines - 

SIGN -

UK Advisory Panel -

World Health Organization -

 

Royal Colleges & Professional organisations

British Association of Dermatologists

British Cardiovascular Society

British Geriatrics Society -

British Psychological Society

British Thoracic Society 

Chartered Society of Physiotherapy

Resuscitation Council

Royal College of Anaesthetists

Royal College of Emergency Medicine

Royal College of General Practitioners

Royal College of Nursing

Royal College of Obstetricians and Gynaecologists

Royal College of Ophthalmologists

Royal College of Pathologists

Royal College of Paediatrics and Child Health

Royal College of Physicians

Royal College of Physicians and Surgeons of Glasgow

Royal College of Physicians of Edinburgh

Royal College of Psychiatrists

Royal College of Radiologists

Royal College of Surgeons

Royal Pharmaceutical Society

 

Social care

Scottish Social Services Council

Social Care Online

 

Evidence summaries

British Islamic Medical Association -

Cochrane Library -

Don't Forget the Bubbles Paediatric evidence summary 

EPPI-Centre-19, University College London - COVID-19: Living map of the evidence

Evidence Aid - Coronavirus (COVID-19): Evidence Collection

Healthcare Improvement Scotland -

NICE -

Acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19

COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19

COVID-19 rapid evidence summary: long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19

COVID-19 rapid evidence summary: anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis

Cytokin absorption devices treating respiratory failure in people with COVID-19

Oxford University - COVID-19 evidence service

SIGN - Assessment of COVID-19 in primary care: evidence review